A study of benzodiazepine users claiming drug-induced psychiatric morbidity

References

• Bergman U, Dahlstrom M. Anxiety and antianxiety drug use in Sweden. In: Pharmacological treatment of anxiety. Stock-holm: National Board of Health and Welfare, Drug Informa-tion Committee; 1988. p. 63–74.
   Google Scholar
• Hollister LE, Muller-Oerlinghausen B, Rickels K, Shader RI. Clinical uses of benzodiazepines. J Clin Psychopharmacol 1993;13\(Suppl 1):1S–169.
   Google Scholar
• Bell C, Nutt DJ. Benzodiazepincs in the treatment of anxiety. Baillieres Clin Psychiatry 1995;1:391–411.
   Google Scholar
• Mattila MJ, Mattila ME, Nuotto E. Measuring drug-alcohol and drug-drug interactions of psychotropic drugs on human skilled performance. In: Hindmarch I, Stonier PD, editors. Hu-man psychopharmacology. Measures and methods Vol 4. Chichester: John Wiley & Sons; 1993. p. 165–94.
   Google Scholar
• Woods JH, Katz JL, Winger G. Benzodiazepines: use, abuse, and consequences Pharmacol Rev 1992;44:151–347.
   Google Scholar
• Cohen S. Current attitudes about the benzodiazepines trial by media. J Psychoactive Drugs 1984;15(1-2):109–13.
   Google Scholar
• Schonberg A. Tranquillizers and hypnotics-sedatives as a so-cial problem in Finland and in Sweden. Nord Alkohol Narkotikatidskr 1997;4(English Suppl.):17–32.
   Google Scholar
• Asberg M. Hearing about benzodiazepincs-conclusions. In: Horing om bensodiazepiner. Nytta och risker. Stockholm: So-cialstyrelsen, Läkemedelsverket (National Board of Health and Welfare and Medical Products Agency); 1992. p. 153–62.
   Google Scholar
• Brahams D. The Swedish medical insurance schemes. The way ahead for the United Kingdom? Lancet 1988;2/9:43–7.
   Google Scholar
• Bergman U, Myrhed M. Benzodiazepine use in Sweden. Lancet 1993;342:37 3–4.
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and statistical manual on mental disorder. 4th ed. Washington (DC): APA; 1994.
   Google Scholar
• Michelini S, Cassano GB, Frare F, Perugi G. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders [review]. Pharmacopsychiatry 1996;29:12 7–34.
   Google Scholar
• Myrhed M, Boethius G, Bergman U. Benzodiazepine prescrip-tion in relation to alcohol dependence in the county of Jämt- land, Sweden. Pharmacoepidemiol Drug Safety 1994;3(Suppl 1):229.
   Google Scholar
• Romach M, Busto U, Somer G, Kaplan H, Sellers E. Clinical aspects of chronic use of alprazolam and lorazepam. Am J Psychiatry 1995;152:1161–7.
   Google Scholar
• Nutt DJ. Benzodiazepine dependence: new insights from basic research. In: Hindmarch I, Beaumont G, Brandon S, Leonard BE, editors. Benzodiazepine s current concepts Chichester: John Wiley; 1990. p. 19–41.
   Google Scholar
• Nutt DJ, Glue P, Lawson C, Wilson S. Flumazenil provoca-tion of panic attacks. Arch Gen Psychiatry 1990;47:91 7–25.
   Google Scholar
• Griffiths RR, Wolf B. Relative abuse liability of different ben-zodiazepines in drug abusers. Psychopharmacology 1990;102:183–90.
   PubMedGoogle Scholar
• Tedeschi G, Smith AT, Dhillon S, Richens A. Rate of entrance of benzodiazepincs into the brain determined by eye movement recording. Br J Clin Pharmacol 1983;15:103–6.
   PubMed Web of Science ®Google Scholar
• Bergman U, Griffiths R. Relative abuse of diazepam and ox-azepam: prescription forgeries and theft/loss reports in Sweden. Drug Alcohol Depend 1986;16:29 3–301.
   Google Scholar
• World Health Organization. Rational use of benzodiazepines. Programme on substance abuse. Geneva: WHO; 1996.
   Google Scholar
• The Royal College of Psychiatrists. Benzodiazepines: risks, benefits or dependence A re-evaluation. London: The College; 1997. Council Report CR59.
   Google Scholar
• Humphreys SA, Hallström C. Benzodiazepine discontinuation phenomena Baillieres Clin Psychiatry 1995;1:485–503.
   Google Scholar
• Balter MB. Benzodiazepine use: 1990 survey data and benefit risk issues: results from a national epidemiological study. 5th World Congress of Biological Psychiatry; 1991; Florence, Italy.
   Google Scholar
• Williams DDR, McBride A. Benzodiazepine s time for reassess-ment. Br J Psychiatry 1998;173:361–2.
   PubMedGoogle Scholar
• Taylor S, McCracken CFM, Wilson KCM, Copeland JRM. Extent and appropriateness of benzodiazepine use. Br J Psychi-atry 1998;173:433–8.
   PubMed Web of Science ®Google Scholar
• FASS-Läkemedel I Sverige 1998. Stockholm: Läkemedelsinfor-mation AB; 1998.
   Google Scholar